# FDA 483 - The Procter & Gamble Manufacturing Company - March 10, 2023

Source: https://www.keypedia.com/records/483/the-procter-gamble-manufacturing-company/bd3adbd8-4ae7-4737-9860-be1df7b8fc6b

> FDA 483 for The Procter & Gamble Manufacturing Company on March 10, 2023. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: The Procter & Gamble Manufacturing Company
- Inspection Date: 2023-03-10
- Product Type: drugs
- Office Name: Atlanta District Office
- Summary: An FDA inspection of The Procter & Gamble Manufacturing Company in Greensboro, NC, an OTC drug manufacturer, revealed two significant observations. The firm was cited for not taking representative samples of components based on scientific rationality and for failing to document production and process control procedures at the time of performance, specifically regarding an emergency action plan.

## Related Documents

- [483 - 2017-11-17](https://www.keypedia.com/records/483/the-procter-gamble-manufacturing-company/7135b04c-f517-4517-88cd-2dc0c2af670b)
- [EIR - 2023-03-10](https://www.keypedia.com/records/eir/the-procter-gamble-manufacturing-company/48610638-4d54-409d-a30b-edb795ac7c79)

## Related Officers

- [issuing_officer](https://www.keypedia.com/people/harshal-j-desai/9ccefb1f-95fc-4a17-9647-eecb5c3ce838)

Company: https://www.keypedia.com/companies/the-procter-gamble-manufacturing-company/ceebac3f-c234-4225-b666-964153cdba97

Office: https://www.keypedia.com/offices/atlanta-district-office/7586d99a-288e-49d1-8c3d-d88b7354b7a7